CYP2B6 and hepatocellular carcinoma: Among HCC patients, the activity of CYP isoforms varies, with CYP3A4, CYP3A5, CYP3A7, CYP2B7, and CYP3A3 being involved in the bioactivation of mutagenic metabolites of AFB1 [48].